Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
6.18
+0.29 (4.92%)
At close: Jun 23, 2026, 4:00 PM EDT
6.20
+0.02 (0.32%)
After-hours: Jun 23, 2026, 7:44 PM EDT
Ernexa Therapeutics Market Cap
Ernexa Therapeutics has a market cap or net worth of $7.21 million as of June 23, 2026. Its market cap has decreased by -35.79% in one year.
Market Cap
7.21M
Enterprise Value
-1.58M
1-Year Change
-35.79%
Ranking
Category
Stock Price
$6.18
Market Cap Chart
Since March 26, 2021, Ernexa Therapeutics's market cap has decreased from $197.27M to $7.21M, a decrease of -96.35%. That is a compound annual growth rate of -46.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 7.21M | -23.47% |
| Dec 31, 2025 | 9.42M | -37.64% |
| Dec 31, 2024 | 15.10M | 55.53% |
| Dec 29, 2023 | 9.71M | -41.18% |
| Dec 30, 2022 | 16.51M | -92.39% |
| Dec 31, 2021 | 217.02M | 10.01% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CDT Equity | 7.29M |
| Creative Medical Technology Holdings | 7.13M |
| Psyence Biomedical | 7.11M |
| Aptorum Group | 6.99M |
| Xenetic Biosciences | 6.74M |
| Can-Fite BioPharma | 6.55M |
| Silo Pharma | 6.52M |
| Acurx Pharmaceuticals | 6.46M |